Actively Recruiting
Does Starting Feeds on the First Day of Life Help Premature Infants Reach Full Volume Feeds Sooner?
Led by University of Tennessee · Updated on 2024-12-12
248
Participants Needed
1
Research Sites
160 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Feeding advancements in ELBW infants have evolved over decades. The fear of causing mortality and morbidity, notably NEC, have made providers cautious when advancing feeds. ELBW infants initially remained NPO for several days before initiating trophic feeds. However, data then showed that there was no increase in mortality and morbidity if trophic feeds were initiated earlier. Then data showed that a short duration of trophic feeds did not increase mortality and morbidity when compared to a prolonged duration. More recent data showed that enteral feeding should be initiated early, preferably within 24 hours of birth, because it may promote feeding tolerance, shorten the time to reach total enteral feeding, and reduce the incidence of extrauterine growth restriction and late onset sepsis without increasing the risk of developing NEC. The management of enteral nutrition in ELBW infants is still very variable. For example, there is no consensus on the optimal time point after birth at which enteral nutrition can be started. This study evaluates the benefits of starting feeds by 6 hours of life Purpose: The primary aim of this study is to evaluate if in infants ≤ 1000g birth weight, is there a benefit initiating feeds by 6 hours of life (compared to current feeding practice data of 3 days of life) on decreasing the time to attain full feeds in the first 30 days of life. The secondary aim is to evaluate if antenatal feeding discussions would streamline feeding management post-delivery.
CONDITIONS
Official Title
Does Starting Feeds on the First Day of Life Help Premature Infants Reach Full Volume Feeds Sooner?
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Infants with birth weight less than or equal to 1000 grams
- Agreement from the clinical care team for infant's participation
- Mothers with pregnancies expecting infants weighing close to or less than 1000 grams
You will not qualify if you...
- Presence of congenital malformations affecting gastrointestinal blood flow
- Infants clinically progressing towards imminent death
- Presence of congenital gastrointestinal obstructions
- Mothers unlikely to deliver infants weighing 1000 grams or less
- Infant receiving more than one pressor or dopamine at doses exceeding 5 mcg/kg/min
- Mothers not in a sound mental state for consent due to critical illness, sedation, or intubation
- Mothers critically ill and unable to participate in consent process
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Regional One Health
Memphis, Tennessee, United States, 38163
Actively Recruiting
Research Team
M
Mohamad Elabiad, MD
CONTACT
I
Ihinosen Edgal, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here